STUDY OBJECTIVES: We examined the 1-y stability of four insomnia symptom profiles: sleep onset insomnia; sleep maintenance insomnia; combined onset and maintenance insomnia; and neither criterion (i.e., insomnia cases that do not meet quantitative thresholds for onset or maintenance problems). Insomnia cases that exhibited the same symptom profile over a 1-y period were considered to be phenotypes, and were compared in terms of clinical and demographic characteristics. DESIGN: Longitudinal. SETTING: Urban, community-based. PARTICIPANTS: Nine hundred fifty-four adults with Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition based current insomnia (46.6 ± 12.6 y; 69.4% female). INTERVENTIONS: None. MEASUREMENTS AND RESULTS: At baseline, participants were divided into four symptom profile groups based on quantitative criteria. Follow-up assessment 1 y later revealed that approximately 60% of participants retained the same symptom profile, and were hence judged to be phenotypes. Stability varied significantly by phenotype, such that sleep onset insomnia (SOI) was the least stable (42%), whereas combined insomnia (CI) was the most stable (69%). Baseline symptom groups (cross-sectionally defined) differed significantly across various clinical indices, including daytime impairment, depression, and anxiety. Importantly, however, a comparison of stable phenotypes (longitudinally defined) did not reveal any differences in impairment or comorbid psychopathology. Another interesting finding was that whereas all other insomnia phenotypes showed evidence of an elevated wake drive both at night and during the day, the 'neither criterion' phenotype did not; this latter phenotype exhibited significantly higher daytime sleepiness despite subthreshold onset and maintenance difficulties. CONCLUSIONS: By adopting a stringent, stability-based definition, this study offers timely and important data on the longitudinal trajectory of specific insomnia phenotypes. With the exception of daytime sleepiness, few clinical differences are apparent across stable phenotypes.
STUDY OBJECTIVES: We examined the 1-y stability of four insomnia symptom profiles: sleep onset insomnia; sleep maintenance insomnia; combined onset and maintenance insomnia; and neither criterion (i.e., insomnia cases that do not meet quantitative thresholds for onset or maintenance problems). Insomnia cases that exhibited the same symptom profile over a 1-y period were considered to be phenotypes, and were compared in terms of clinical and demographic characteristics. DESIGN: Longitudinal. SETTING: Urban, community-based. PARTICIPANTS: Nine hundred fifty-four adults with Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition based current insomnia (46.6 ± 12.6 y; 69.4% female). INTERVENTIONS: None. MEASUREMENTS AND RESULTS: At baseline, participants were divided into four symptom profile groups based on quantitative criteria. Follow-up assessment 1 y later revealed that approximately 60% of participants retained the same symptom profile, and were hence judged to be phenotypes. Stability varied significantly by phenotype, such that sleep onset insomnia (SOI) was the least stable (42%), whereas combined insomnia (CI) was the most stable (69%). Baseline symptom groups (cross-sectionally defined) differed significantly across various clinical indices, including daytime impairment, depression, and anxiety. Importantly, however, a comparison of stable phenotypes (longitudinally defined) did not reveal any differences in impairment or comorbid psychopathology. Another interesting finding was that whereas all other insomnia phenotypes showed evidence of an elevated wake drive both at night and during the day, the 'neither criterion' phenotype did not; this latter phenotype exhibited significantly higher daytime sleepiness despite subthreshold onset and maintenance difficulties. CONCLUSIONS: By adopting a stringent, stability-based definition, this study offers timely and important data on the longitudinal trajectory of specific insomnia phenotypes. With the exception of daytime sleepiness, few clinical differences are apparent across stable phenotypes.
Authors: Kristen C Stone; Daniel J Taylor; Christina S McCrae; Anupama Kalsekar; Kenneth L Lichstein Journal: Sleep Med Rev Date: 2008-06-06 Impact factor: 11.609
Authors: Catherine D Jefferson; Christopher L Drake; Holly M Scofield; Eric Myers; Tara McClure; Timothy Roehrs; Thomas Roth Journal: Sleep Date: 2005-05 Impact factor: 5.849
Authors: Thomas Roth; Gary Zammit; Alan Lankford; David Mayleben; Theresa Stern; Verne Pitman; David Clark; John L Werth Journal: Sleep Date: 2010-04 Impact factor: 5.849
Authors: Thomas Roth; Catherine Coulouvrat; Goeran Hajak; Matthew D Lakoma; Nancy A Sampson; Victoria Shahly; Alicia C Shillington; Judith J Stephenson; James K Walsh; Ronald C Kessler Journal: Biol Psychiatry Date: 2010-12-31 Impact factor: 13.382
Authors: Charles M Morin; Lynda Bélanger; Mélanie LeBlanc; Hans Ivers; Josée Savard; Colin A Espie; Chantal Mérette; Lucie Baillargeon; Jean-Pierre Grégoire Journal: Arch Intern Med Date: 2009-03-09
Authors: Megan R Crawford; Diana A Chirinos; Toni Iurcotta; Jack D Edinger; James K Wyatt; Rachel Manber; Jason C Ong Journal: J Clin Sleep Med Date: 2017-07-15 Impact factor: 4.062
Authors: David A Kalmbach; James L Abelson; J Todd Arnedt; Zhuo Zhao; Jessica R Schubert; Srijan Sen Journal: Sleep Med Date: 2018-12-14 Impact factor: 3.492
Authors: David A Kalmbach; Deirdre A Conroy; Hayley Falk; Vani Rao; Durga Roy; Matthew E Peters; Timothy E Van Meter; Frederick K Korley Journal: Sleep Date: 2018-10-01 Impact factor: 5.849
Authors: Vivek Pillai; Philip Cheng; David A Kalmbach; Timothy Roehrs; Thomas Roth; Christopher L Drake Journal: Sleep Date: 2016-04-01 Impact factor: 5.849
Authors: Anders M Fjell; Donatas Sederevicius; Markus H Sneve; Ann-Marie Glasø de Lange; Anne CecilieSjøli Bråthen; Ane-Victoria Idland; Leiv Otto Watne; Yunpeng Wang; Céline Reinbold; Valerija Dobricic; Fabian Kilpert; Kaj Blennow; Henrik Zetterbergj; Shengjun Hong; Lars Bertram; Kristine B Walhovd Journal: Cereb Cortex Date: 2020-04-14 Impact factor: 5.357